HPE composable infrastructure platform future-proofs IT at Netherlands Cancer Institute case study

(PDF 942 KB)

HPE Synergy composable infrastructure platform and HPE ProLiant DL380 Gen10 cluster enable the Netherlands Cancer Institute to accelerate research to advance discoveries of new cancer treatments and enhance efficiency.